(Q35791799)

10 August 2017

title

Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients (English)

1 reference

10 August 2017

1 reference

7

Eric Daugas

1 reference

10 August 2017

3

Pierre-Yves Ancel

0 references

author name string

Pierre-Antoine Michel

1

1 reference

10 August 2017

Karine Dahan

2

1 reference

10 August 2017

Emmanuelle Plaisier

4

1 reference

10 August 2017

Rachid Mojaat

5

1 reference

10 August 2017

Sophie De Seigneux

6

1 reference

10 August 2017

Marie Matignon

8

1 reference

10 August 2017

Laurent Mesnard

9

1 reference

10 August 2017

Alexandre Karras

10

1 reference

10 August 2017

Hélène François

11

1 reference

10 August 2017

Agathe Pardon

12

1 reference

10 August 2017

Valérie Caudwell

13

1 reference

10 August 2017

Hanna Debiec

14

1 reference

10 August 2017

Pierre Ronco

15

1 reference

10 August 2017

publication date

1 January 2011

1 reference

10 August 2017

1 reference

10 August 2017

volume

1

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

251-261

1 reference

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Alkylating agents in membranous nephropathy: efficacy proven beyond doubt

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Rituximab therapy for membranous nephropathy: a systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Diagnosis and natural course of membranous nephropathy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Membranous nephropathy: recent travels and new roads ahead

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Rituximab treatment of idiopathic membranous nephropathy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Rituximab in idiopathic membranous nephropathy: a one-year prospective study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous Nephropathy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Rituximab for Idiopathic Membranous Nephropathy: Who Can Benefit?

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290855

Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis)

15 November 2018

1 reference

12 December 2020

Rituximab for idiopathic membranous nephropathy

1 reference

12 December 2020

Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies

1 reference

12 December 2020

An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies

1 reference

12 December 2020

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy

1 reference

12 December 2020

CD20-positive infiltrates in human membranous glomerulonephritis

1 reference

12 December 2020

Identifiers

DOI

10.1159/000333068

1 reference

10 August 2017

1 reference

10 August 2017

1 reference